Presentation
13 March 2024 PRESTO, a novel non-invasive tool for detection and assessment of skin lesions based on protoporphyrin IX (PPIX) fluorescence and the microvascular dynamics of pressing on the tissue
Author Affiliations +
Abstract
Introducing PRESS (Pressure Enhanced Sensing Surgery) – a groundbreaking method to image hypoxia in skin lesions. Chaotic, weak blood vessels in tumors cause microregional chronic and cycling hypoxia, and low-pressure blood flow. PRESS takes advantage of the FDA-approved drug aminolaevulinic acid, to imply the synthesis of Protoporphyrin IX (PpIX) in tissue. PpIX's delayed fluorescence (DF) serves as a unique indicator of local oxygen levels, particularly in mitochondria, making it ideal for tissue oxygen measurement. Enhanced signal resolution is achieved through palpation, capturing both chronic and pressure-induced transient hypoxia. In dermatology, PRESS shows great promise for assessing tissue types and malignancy margins, especially with the widespread use of ALA for skin lesion treatments. Preliminary results from the first clinical trial highlight its potential in dermatological applications.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Arthur F. Pétusseau, Petr Bruza, and Brian Pogue "PRESTO, a novel non-invasive tool for detection and assessment of skin lesions based on protoporphyrin IX (PPIX) fluorescence and the microvascular dynamics of pressing on the tissue", Proc. SPIE PC12816, Photonics in Dermatology and Plastic Surgery 2024, PC1281606 (13 March 2024); https://doi.org/10.1117/12.3004512
Advertisement
Advertisement
KEYWORDS
Tissues

Fluorescence

Hypoxia

Skin

Dermatology

Reflection

Resolution enhancement technologies

Back to Top